About Sanofi-Aventis
.
Sanofi- Aventis is a French pharmaceutical company, with its headquarters at Paris. Jean-François Dehecq, the Chairman and CEO leads this French pharmaceutical company. It undertakes research, development, manufacturing and marketing exclusively in the prescription market. Sanofi-Aventis was formed in 2004, when Sanofi- Synthélabo was united with Aventis as an end result of intercession by the French government.
It has made a worldwide impact by making its presence felt in more than 100 countries. It is the world’s third biggest pharmaceutical company, only subsequent to Pfizer and Glaxo Smith Kline. Sanofi-Aventis includes more than 25 research and development centers, which are laid out over 3 most important continents counting countries like United States, Canada, United Kingdom, France, Germany, Italy, Spain and Japan.
This French pharmaceutical firm primarily aims to sustain human well being and battle disease all over the world, satisfying an essential obligation towards mankind. It offers the wide spectrum of vaccines against 20 bacterial and viral diseases. It covers up therapeutic areas such as:
1. Central nervous system
2. Metabolic disorders
3. Vaccines
4. Internal medicines
5. Cardiovascular diseases
6. Oncology
7. Thrombosis
|
